GlobeNewswire: SynCardia Systems, LLC. Contains the last 10 of 3 releaseshttps://bbtzndatsun.co.za?sanitizer=External?Length=42020-08-08T18:34:16ZGlobeNewswirehttps://bbtzndatsun.co.za?sanitizer=External?Length=4newsdesk@globenewswire.com (NewsDesk)https://bbtzndatsun.co.za?sanitizer=news-release/2020/04/09/2014003/0/en/Face-Shields-for-Medical-Staff-Now-Available-from-SynCardia-Systems-LLC.html?f=22&fvtc=4&fvtv=58841Face Shields for Medical Staff Now Available from SynCardia Systems, LLC2020-04-09T02:23:54Z<![CDATA[Tucson, Arizona, April 08, 2020 (GLOBE NEWSWIRE) -- SynCardia Systems, LLC announced today that the company has begun shipping clear face shields designed to help protect healthcare workers from potentially infectious aerosolized respiratory secretions they are exposed to while caring for patients with suspected or confirmed COVID-19 infections.]]>https://bbtzndatsun.co.za?sanitizer=news-release/2020/04/06/2012483/0/en/80-Ethanol-Hand-Sanitizer-Now-Available-from-SynCardia-Systems-LLC.html?f=22&fvtc=4&fvtv=5884180% Ethanol Hand Sanitizer Now Available from SynCardia Systems, LLC2020-04-06T22:13:06Z<![CDATA[Tucson, AZ, April 06, 2020 (GLOBE NEWSWIRE) -- SynCardia Systems, LLC announced today that the company has begun manufacturing and selling an 80% ethanol (alcohol) hand sanitizer. Hand hygiene is an important part of the U.S. response to COVID-19. Our hand sanitizer complies with the guidance issued by the FDA, with recommendations from the WHO, for compounding of alcohol-based sanitizer products including utilizing the maximum recommended ethanol concentration.1]]>https://bbtzndatsun.co.za?sanitizer=news-release/2020/03/09/1997447/0/en/SynCardia-Systems-LLC-50cc-temporary-Total-Artificial-Heart-TAH-t-Now-FDA-Approved.html?f=22&fvtc=4&fvtv=58841SynCardia Systems, LLC. 50cc temporary Total Artificial Heart (TAH-t) Now FDA Approved2020-03-09T18:15:33Z<![CDATA[TUCSON, AZ, March 09, 2020 (GLOBE NEWSWIRE) -- SynCardia Systems, LLC announced today that the 50cc temporary Total Artificial Heart System (50cc TAH-t) has received U.S. Food and Drug Administration (FDA) approval as a bridge to transplantation in cardiac transplant eligible patients at risk of imminent death from biventricular failure. With this approval, physicians can now offer the TAH-t to patients with smaller thoracic dimensions including small statured adults, and some pediatric patients.  The SynCardia TAH-t is the only dischargeable biventricular support device approved by the FDA which can allow patients to recover at home while maintaining high priority (UNOS Status 2) for a donor heart.]]>